Trials / Completed
CompletedNCT00428701
An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium
An Open-Label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium I.V. (Esomeprazole Sodium) 40mg BID for up to 72 Hours
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to see if Nexium I.V. can reduce and control stomach acid in mechanically ventilated, critically ill patients in an Intensive Care Unit setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole Sodium |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2007-01-30
- Last updated
- 2011-01-24
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00428701. Inclusion in this directory is not an endorsement.